Immunogenicity and Safety of GSK Biologicals' Thimerosal-Free TIV Flu Vaccine Versus a Licensed Comparator in Children.
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 17 Jun 2009 Actual patient number (3318) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.